Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | October 01, 2020 | October 05, 2020 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 16, 2024 | May 17, 2024 |
| STRYKER CORPSYK · Entity 369 | President & CEO | February 06, 2012 | February 08, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date October 01, 2020 · Filed October 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,000 |
Reported balance
After 2020-10-01 transaction · row 1
1 source rowRow 1 · 2020-10-01 · Grant · Acquired 498 · Balance 8,000 F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020.
ILLUMINA, INC.
Report date May 16, 2024 · Filed May 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,129 |
Reported balance
After 2024-05-16 transaction · row 1
1 source rowRow 1 · 2024-05-16 · Grant · Acquired 2,622 · Balance 4,129 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
STRYKER CORP
Report date February 06, 2012 · Filed February 08, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,002 |
Reported balance
After 2012-02-06 transaction · row 1
1 source rowRow 1 · 2012-02-06 · Exercise / conversion · Acquired 5,000 · Balance 132,002 |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $46.85 · Expires 2016-02-06 | Direct | 0 |
Reported balance
After 2012-02-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2012-02-06 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k Plan | 716 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 716 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian | 200 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 1,423,837 · Balance 0 F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectMacMillan Family Trust | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 1,146,829 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.64 · Expires 2026-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-07 · Disposition to issuer · Disposed 160,565 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-07 · Disposition to issuer · Disposed 159,339 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-07 · Disposition to issuer · Disposed 768,639 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-11-12 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-07 · Disposition to issuer · Disposed 151,071 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.61 · Expires 2029-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-07 · Disposition to issuer · Disposed 152,529 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.35 · Expires 2030-11-09 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-07 · Disposition to issuer · Disposed 123,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.13 · Expires 2031-11-08 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-07 · Disposition to issuer · Disposed 118,877 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.35 · Expires 2032-11-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-04-07 · Disposition to issuer · Disposed 106,300 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.94 · Expires 2033-11-14 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-04-07 · Disposition to issuer · Disposed 117,829 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.39 · Expires 2034-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-04-07 · Disposition to issuer · Disposed 117,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 190,400 |
Reported balance
After 2026-04-07 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-04-07 · Grant · Acquired 190,400 · Balance 190,400 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-04-07 · Disposition to issuer · Disposed 190,400 · Balance 0 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan.
F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F5: For Footnote (5), see Remarks below.
F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock.
F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU.
TEXAS INSTRUMENTS INC
Report date February 17, 2012 · Filed February 21, 2012
Section 16 reporting ended · disclosed 2012-02-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 5,899.25 |
Reported balance
After 2012-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2012-02-17 · Grant · Acquired 98.3 · Balance 5,899.25 F1: Security converts to common stock on a one-for-one basis. F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. |
| Common StockSEC Table I · non-derivative | Direct | 13,977 |
Reported balance
Holding disclosure · report date 2012-02-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 13,977 |
Filing footnotes · ownership attribution and instrument terms
F1: Security converts to common stock on a one-for-one basis.
F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerPerformance Stock Units · Derivative | 190,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 14 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 190,400 shares Expires not disclosed F6 · derivative.exercise_price: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7 · price: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F7 · derivative.exercise_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F7 · derivative.expiration_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantPerformance Stock Units · Derivative | 190,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 13 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,400 Underlying: Common Stock · 190,400 shares Expires not disclosed F6 · derivative.exercise_price: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7 · price: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F7 · derivative.exercise_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F7 · derivative.expiration_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 117,801 | Not disclosed Strike: $79.39 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 12 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,801 shares Expires 2034-11-11 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 117,829 | Not disclosed Strike: $71.94 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 11 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,829 shares Expires 2033-11-14 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 106,300 | Not disclosed Strike: $74.35 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 10 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,300 shares Expires 2032-11-07 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 118,877 | Not disclosed Strike: $71.13 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 9 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 118,877 shares Expires 2031-11-08 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 123,801 | Not disclosed Strike: $68.35 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 8 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 123,801 shares Expires 2030-11-09 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 152,529 | Not disclosed Strike: $45.61 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 7 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 152,529 shares Expires 2029-11-11 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 151,071 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 6 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 151,071 shares Expires 2028-11-12 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 768,639 | Not disclosed Strike: $40.85 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 768,639 shares Expires 2027-12-01 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 159,339 | Not disclosed Strike: $40.85 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 159,339 shares Expires 2027-12-01 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 160,565 | Not disclosed Strike: $37.64 | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 160,565 shares Expires 2026-12-01 F5 · price: For Footnote (5), see Remarks below. F5 · derivative.exercise_date: For Footnote (5), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerCommon Stock | 1,146,829 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · MacMillan Family Trust Disclosed balance after: 0 F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F4 · price: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerCommon Stock | 1,423,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000065 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3 · price: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:33 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 6,874 | $74.15 | $509,707.10 |
DisclosureSEC source: 0000859737-25-000088 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,423,837 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 6,679 | $74.60 | $498,253.40 |
DisclosureSEC source: 0000859737-25-000064 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,430,711 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 169,582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-25-000064 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,390 F3 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 10, 2025. F4 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 50,405 | $74.10 | $3,735,010.50 |
DisclosureSEC source: 0000859737-25-000064 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,267,808 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:51 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 83,589 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-25-000046 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,318,213 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| September 22, 2025 Filed Sep 23, 2025 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 138,358 | $0.00 Strike: $39.96 | $0.00 |
DisclosureSEC source: 0000859737-25-000028 · form4.xml · derivative · entry 6 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 138,358 shares Expires 2025-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025. F7 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 5, 2015. Read SEC document |
| September 22, 2025 Filed Sep 23, 2025 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 38,700 | $67.32 | $2,605,284.00 |
DisclosureSEC source: 0000859737-25-000028 · form4.xml · nonDerivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,234,624 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025. F6 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $67.28 to $67.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F3 · balance_after: Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| September 22, 2025 Filed Sep 23, 2025 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 77,418 | $67.04 | $5,190,102.72 |
DisclosureSEC source: 0000859737-25-000028 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,273,324 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025. F5 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $66.474 to $67.275 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F3 · balance_after: Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| September 22, 2025 Filed Sep 23, 2025 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 22,240 | $66.13 | $1,470,731.20 |
DisclosureSEC source: 0000859737-25-000028 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,350,742 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025. F4 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $65.525 to $66.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F3 · balance_after: Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| September 22, 2025 Filed Sep 23, 2025 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 138,358 | $39.96 | $5,528,785.68 |
DisclosureSEC source: 0000859737-25-000028 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,372,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F3 · balance_after: Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:49 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 6,860 | $77.54 | $531,924.40 |
DisclosureSEC source: 0001127602-24-027528 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,234,278 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 01:50 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 117,801 | $0.00 Strike: $79.39 | $0.00 |
DisclosureSEC source: 0001127602-24-027131 · form4.xml · derivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,801 Underlying: Common Stock · 117,801 shares Expires 2034-11-11 F5 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 11, 2024. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 01:50 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 39,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-027131 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,241,138 F3 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 11, 2024. F4 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 01:50 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 68,447 | $78.76 | $5,390,885.72 |
DisclosureSEC source: 0001127602-24-027131 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,201,461 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 01:50 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 6,214 | $79.29 | $492,708.06 |
DisclosureSEC source: 0001127602-24-027131 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,269,908 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 118,560 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026732 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,276,122 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 44,039 | $0.00 Strike: $26.21 | $0.00 |
DisclosureSEC source: 0001127602-24-021362 · form4.xml · derivative · entry 6 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,039 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first five anniversaries of the grant date, November 7, 2014. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 20,228 | $82.32 | $1,665,168.96 |
DisclosureSEC source: 0001127602-24-021362 · form4.xml · nonDerivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,157,562 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F5 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $82.00 to $82.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 16,177 | $81.44 | $1,317,454.88 |
DisclosureSEC source: 0001127602-24-021362 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,177,790 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F4 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $81.00 to $81.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 7,634 | $80.60 | $615,300.40 |
DisclosureSEC source: 0001127602-24-021362 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,193,967 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $80.00 to $80.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 44,039 | $26.21 | $1,154,262.19 |
DisclosureSEC source: 0001127602-24-021362 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,201,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 3,672 | $0.00 Strike: $26.21 | $0.00 |
DisclosureSEC source: 0001127602-24-020736 · form4.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,039 Underlying: Common Stock · 3,672 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first five anniversaries of the grant date, November 7, 2014. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 3,672 | $80.13 | $294,222.67 |
DisclosureSEC source: 0001127602-24-020736 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,157,562 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F4 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $80.00 to $80.29 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F3 · balance_after: Includes 349 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 3,672 | $26.21 | $96,243.12 |
DisclosureSEC source: 0001127602-24-020736 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,161,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F3 · balance_after: Includes 349 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:07 UTC | HOLOGIC INC HOLX · Entity 12463 | GiftCommon Stock | 57,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016554 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,157,213 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| May 16, 2024 Filed May 17, 2024 22:09 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015927 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,129 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 20:30 UTC | HOLOGIC INC HOLX · Entity 12463 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013263 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,215,088 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:30 UTC | HOLOGIC INC HOLX · Entity 12463 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013263 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,227,088 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 29, 2023 Filed Dec 1, 2023 21:04 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 47,711 | $0.00 Strike: $26.21 | $0.00 |
DisclosureSEC source: 0001127602-23-028585 · form4.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,711 Underlying: Common Stock · 47,711 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first five anniversaries of the grant date, November 7, 2014. Read SEC document |
| November 29, 2023 Filed Dec 1, 2023 21:04 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 47,711 | $70.41 | $3,359,188.38 |
DisclosureSEC source: 0001127602-23-028585 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,239,088 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $69.95 to $70.85 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 29, 2023 Filed Dec 1, 2023 21:04 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 47,711 | $26.21 | $1,250,505.31 |
DisclosureSEC source: 0001127602-23-028585 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,286,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted August 30, 2023 to exercise and sell expiring stock options. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:43 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 117,829 | $0.00 Strike: $71.94 | $0.00 |
DisclosureSEC source: 0001127602-23-027629 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,829 Underlying: Common Stock · 117,829 shares Expires 2033-11-14 F4 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 14, 2023. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:43 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 40,832 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-027629 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,239,088 F1 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 14, 2023. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 22:12 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 65,811 | $67.20 | $4,422,499.20 |
DisclosureSEC source: 0001127602-23-027277 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,198,256 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 22:12 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 5,442 | $68.27 | $371,525.34 |
DisclosureSEC source: 0001127602-23-027277 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,264,067 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2023 Filed Nov 8, 2023 22:17 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 3,974 | $68.37 | $271,702.38 |
DisclosureSEC source: 0001127602-23-027047 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,269,509 F4 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.